210 related articles for article (PubMed ID: 16634703)
1. Emerging drugs for irritable bowel syndrome.
Bradesi S; Tillisch K; Mayer E
Expert Opin Emerg Drugs; 2006 May; 11(2):293-313. PubMed ID: 16634703
[TBL] [Abstract][Full Text] [Related]
2. Investigational agents for the irritable bowel syndrome.
Ghaith O; El-Halabi M; Hashash JG; Sharara AI
Expert Opin Investig Drugs; 2010 Oct; 19(10):1161-78. PubMed ID: 20836617
[TBL] [Abstract][Full Text] [Related]
3. Novel pharmacological therapies for irritable bowel syndrome.
Corsetti M; Whorwell P
Expert Rev Gastroenterol Hepatol; 2016 Jul; 10(7):807-15. PubMed ID: 26907518
[TBL] [Abstract][Full Text] [Related]
4. New therapeutic perspectives in irritable bowel syndrome: Targeting low-grade inflammation, immuno-neuroendocrine axis, motility, secretion and beyond.
Sinagra E; Morreale GC; Mohammadian G; Fusco G; Guarnotta V; Tomasello G; Cappello F; Rossi F; Amvrosiadis G; Raimondo D
World J Gastroenterol; 2017 Sep; 23(36):6593-6627. PubMed ID: 29085207
[TBL] [Abstract][Full Text] [Related]
5. Novel investigational drugs for constipation-predominant irritable bowel syndrome: a review.
Mosińska P; Salaga M; Fichna J
Expert Opin Investig Drugs; 2016; 25(3):275-86. PubMed ID: 26765585
[TBL] [Abstract][Full Text] [Related]
6. New and Investigational Agents for Irritable Bowel Syndrome.
Wadhwa A; Camilleri M; Grover M
Curr Gastroenterol Rep; 2015 Dec; 17(12):46. PubMed ID: 26446557
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic Approach for Irritable Bowel Syndrome: Old and New Strategies.
Usai-Satta P; Bellini M; Lai M; Oppia F; Cabras F
Curr Clin Pharmacol; 2018; 13(3):164-172. PubMed ID: 30084333
[TBL] [Abstract][Full Text] [Related]
8. Current and emerging treatments for irritable bowel syndrome with constipation and chronic idiopathic constipation: focus on prosecretory agents.
Thomas RH; Luthin DR
Pharmacotherapy; 2015 Jun; 35(6):613-30. PubMed ID: 26016701
[TBL] [Abstract][Full Text] [Related]
9. The role of experimental models in developing new treatments for irritable bowel syndrome.
Holschneider DP; Bradesi S; Mayer EA
Expert Rev Gastroenterol Hepatol; 2011 Feb; 5(1):43-57. PubMed ID: 21309671
[TBL] [Abstract][Full Text] [Related]
10. Novel therapeutic approaches in IBS.
Bradesi S; Mayer EA
Curr Opin Pharmacol; 2007 Dec; 7(6):598-604. PubMed ID: 18006379
[TBL] [Abstract][Full Text] [Related]
11. Rationale for using serotonergic agents to treat irritable bowel syndrome.
Baker DE
Am J Health Syst Pharm; 2005 Apr; 62(7):700-11; quiz 712-3. PubMed ID: 15790796
[TBL] [Abstract][Full Text] [Related]
12. Tegaserod for the treatment of irritable bowel syndrome and chronic constipation.
Evans BW; Clark WK; Moore DJ; Whorwell PJ
Cochrane Database Syst Rev; 2007 Oct; (4):CD003960. PubMed ID: 17943807
[TBL] [Abstract][Full Text] [Related]
13. Options for patients with irritable bowel syndrome: contrasting traditional and novel serotonergic therapies.
Johanson JF
Neurogastroenterol Motil; 2004 Dec; 16(6):701-11. PubMed ID: 15601419
[TBL] [Abstract][Full Text] [Related]
14. Challenges to the therapeutic pipeline for irritable bowel syndrome: end points and regulatory hurdles.
Camilleri M; Chang L
Gastroenterology; 2008 Dec; 135(6):1877-91. PubMed ID: 18848833
[TBL] [Abstract][Full Text] [Related]
15. Update in the pharmaceutical therapy of the irritable bowel syndrome.
Thielecke F; Maxion-Bergemann S; Abel F; Gonschior AK
Int J Clin Pract; 2004 Apr; 58(4):374-81. PubMed ID: 15161123
[TBL] [Abstract][Full Text] [Related]
16. LX-1031, a tryptophan 5-hydroxylase inhibitor that reduces 5-HT levels for the potential treatment of irritable bowel syndrome.
Camilleri M
IDrugs; 2010 Dec; 13(12):921-8. PubMed ID: 21154152
[TBL] [Abstract][Full Text] [Related]
17. Irritable bowel syndrome: recent and novel therapeutic approaches.
Andresen V; Camilleri M
Drugs; 2006; 66(8):1073-88. PubMed ID: 16789793
[TBL] [Abstract][Full Text] [Related]
18. Pathogenesis, Experimental Models and Contemporary Pharmacotherapy of Irritable Bowel Syndrome: Story About the Brain-Gut Axis.
Tsang SW; Auyeung KK; Bian ZX; Ko JK
Curr Neuropharmacol; 2016; 14(8):842-856. PubMed ID: 27009115
[TBL] [Abstract][Full Text] [Related]
19. Drug discovery approaches to irritable bowel syndrome.
Hornby PJ
Expert Opin Drug Discov; 2015; 10(8):809-24. PubMed ID: 26193876
[TBL] [Abstract][Full Text] [Related]
20. [Novel therapeutic approaches in the treatment of irritable bowel syndrome].
Pregun I; Herszényi L; Juhász M; Miheller P; Tulassay Z
Orv Hetil; 2007 May; 148(20):923-8. PubMed ID: 17509972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
